![Andy Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Andy A.
Liu currently works at Cellomics, Inc., as Group Chief Executive Officer from 2023.
Postes actifs de Andy Liu
Sociétés | Poste | Début |
---|---|---|
Cellomics, Inc.
![]() Cellomics, Inc. Medical SpecialtiesHealth Technology Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA. | Directeur Général | 24/10/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cellomics, Inc.
![]() Cellomics, Inc. Medical SpecialtiesHealth Technology Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA. | Health Technology |